Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NAE1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
mRNA | TEX15 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | PCDHGB1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | TRMU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0005 |
mRNA | CBFB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | RPL32 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | TM7SF3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
mRNA | PCDHGC5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | SEC14L2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
mRNA | PLA2G2E | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |